Ignite Creation Date:
2025-12-18 @ 8:26 AM
Ignite Modification Date:
2025-12-18 @ 8:26 AM
Study NCT ID:
NCT07038915
Status:
None
Last Update Posted:
2025-08-05 00:00:00
First Post:
2025-06-18 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2025-06-18 00:00:00
First Submit QC Date:
None
Study First Post Date:
2025-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-31 00:00:00
Last Update Post Date:
2025-08-05 00:00:00
Last Update Post Date Type:
ACTUAL